<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801191/" ref="ordinalpos=4700&amp;ncbi_uid=5596005&amp;link_uid=PMC3801191" image-link="/pmc/articles/PMC3801191/figure/F1/" class="imagepopup">Figure 1. Summary of the Canonical Wnt <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span>.  From: Estrogen Regulation of Dkk1 and Wnt/?-Catenin <span class="highlight" style="background-color:">Signaling</span> in Neurodegenerative Disease. </a></div><br /><div class="p4l_captionBody">This figure briefly summarizes canonical Wnt signaling. <b>A,</b> In the absence of Wnt ligand, cytosolic β-Catenin is phosphorylated, ubiquitinated, and degraded by the proteasome to prevent the expression of Wnt target genes. <b>B,</b> However, in the presence of Wnt ligand, cytosolic β-Catenin is stabilized and translocates to the nucleus, where it acts as a co-activator and facilitates the transcription of Wnt target genes. Dkk1 antagonizes canonical Wnt signaling by binding to the Wnt co-receptor LRP5/6 and preventing formation of the Wnt-Frizzled-LRP5/6 complex. See text for further details. APC, adenomatous polyposis coli, β-Cat, β-Catenin; β-TrCP, Beta-Transducing repeat-Containing Protein; Dvl, Disheveled; CKI, Casein Kinase I; Dkk1, Dickkopf-1; GSK3β, Glycogen Synthase Kinase 3β; LRP5/6, Low Density Lipoprotein-Related Protein 5/6; TCF/LEF, T Cell Factor/Lymphoid Enhancing Factor; Ub, Ubiquitin; Wnt, Wingless.</div></div>